Important notice regarding Inveltys

Posted in Latest News on August 7, 2019.

Important notice regarding Inveltys:

The board approved Inveltys (loteprednol etabonate ophthalmic suspension) 1% for addition to Rule 64B13-18.002. Effective August 5, 2019, Licensees are now permitted to prescribe Inveltys.



More Latest News

Second Quarter Performance Report
April 12, 2022

Released for the
2022 – 2023 Fiscal Year Continue reading


Fraudulent Email Alert
February 23, 2022

The Department of Health, Division of Medical Quality Assurance, is warning Florida health care practitioners about fraudulent emails that have been received by multiple licensees. Continue reading